Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and the safety of the association of
carboplatine and liposomal doxorubicin in patient with ovarian cancer in relapse, sensitive
to platin.